193 - What’s on the Multiplex Molecular Panel Menu for ID Diagnostics?

Saturday, October 19, 2024

8:00 AM – 9:00 AM US PT

Location: 502 A

All relevant financial relationships have been mitigated.

CME Credits: Maximum of 1 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1 hours of MOC Credit
CNE Credits: Maximum of 1 hours of ANCC Credit
ACPE Credits: ACPE 1 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

Moderator(s)

Patricia Simner, PhD

Associate Professor, Director of Bacteriology
Johns Hopkins School of Medicine
Baltimore, MD, United States
Jennifer Dien Bard, PhD, D(ABMM), FIDSA, FAAM (she/her/hers)

Chief of Clinical Operations, Director of Clinical Microbiology and Virology
Children's Hospital Los Angeles; University of Southern California

Faculty(s)

Niaz Banaei, MD

Associate Professor of Pathology and Medicine (Infectious Diseases & Geographic Medicine)
Stanford University School of Medicine
Palo Alto, CA, United States
Jennifer Dien Bard, PhD, D(ABMM), FIDSA, FAAM (she/her/hers)

Chief of Clinical Operations, Director of Clinical Microbiology and Virology
Children's Hospital Los Angeles; University of Southern California

Disclosure(s):

Patricia J. Simner, PhD: Affinity Biosensors: Grant/Research Support; BD Diagnostics: Grant/Research Support; bioMérieux: Grant/Research Support; Entasis: Personal fees; GeneCapture: Personal Fees; Merck: Personal fees; OpGen Inc: Grant/Research Support; Qiagen: Grant/Research Support; Shionogi: Personal fees; T2 Biosystems: Grant/Research Support

Jennifer Dien Bard, PhD, D(ABMM), FIDSA, FAAM: Abbott Molecular Inc: Grant/Research Support (Terminated); Becton, Dickinson and Company (BD): Advisor/Consultant (Ongoing); bioMerieux Inc.: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); Cepheid, Inc: Grant/Research Support (Ongoing); Diasorin Molecular LLC: Grant/Research Support (Ongoing); Genetic Signatures: Advisor/Consultant (Terminated), Grant/Research Support (Terminated); Hologic: Grant/Research Support (Ongoing); Luminex: Grant/Research Support (Ongoing); Thermo Fisher: Honoraria (Ongoing)

Niaz Banaei, MD: No financial relationships to disclose

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe practical implications of launching novel multiplex panels, including pre-analytical, testing and reporting strategies to ensure quality of results;
describe the future and challenges of implementation of multiplex panels for infectious diseases.

Presentations:

8:00 AM – 8:30 AM US PT

Clinical Deployment of Novel Multiplex Panels
Speaker: Niaz Banaei, MD – Stanford University School of Medicine
8:30 AM – 9:00 AM US PT

Future Directions for Multiplexed Infectious Disease Panel Testing
Speaker: Jennifer Dien Bard, PhD, D(ABMM), FIDSA, FAAM (she/her/hers) – Children's Hospital Los Angeles; University of Southern California